NICOLE SCHNEIDER: Open Payments
NPI 1952629339 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 7 companies in 2025. Trend: 2023 $91 · 2024 $288 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $59 |
| Optinose US, Inc. | 2 | $33 |
| GENZYME CORPORATION | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Stryker Corporation | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: Xhance, Xolair, Itovebi, DUPIXENT, KEYTRUDA, NEFFY, SCOPIS ENT, Ryaltris.
Industry payments across SC — which companies pay providers there.
